• URB597 (KDS-4103): Selective FAAH Inhibition for Endocannabi

  2026-05-27

  URB597 (KDS-4103) is a potent, selective FAAH inhibitor widely used in neuroplasticity and neuroinflammation research. It reliably increases anandamide levels in the brain without directly affecting cannabinoid receptors. This dossier details its mechanism, benchmarks, and workflow integration for endocannabinoid signaling modulation.

• Melittin: Bioactive Peptide Workflows for Cell Signaling Mod

  2026-05-26

  Melittin, a powerful bioactive peptide, unlocks precision in dissecting G protein-coupled receptor signaling and apoptosis mechanisms. This guide delivers experimental protocols, advanced troubleshooting, and real-world use-cases that maximize Melittin's value for cancer biology and signal transduction research.

• Propranolol Modulates Metabolic Pathways to Improve Burn Out

  2026-05-26

  This article reviews a randomized controlled trial that demonstrates how propranolol therapy in severely burned patients reprograms key metabolic and lipidomic signatures, leading to improved clinical outcomes. The findings provide mechanistic clarity on propranolol’s modulation of adipose-tissue pathways, offering new directions for metabolic intervention research.

• JC-1: Benchmark Fluorescent Probe for Mitochondrial Assays

  2026-05-25

  JC-1 is a gold-standard fluorescent probe for quantifying mitochondrial membrane potential changes, enabling reliable detection of mitochondrial dysfunction and apoptosis in cellular bioenergetics studies. Its ratiometric fluorescence and high chemical purity make it the preferred tool for robust, quantitative analysis in mitochondrial research.

• Targeting c-Myc/Max Dimerization: 10074-G5 in Translational

  2026-05-25

  This thought-leadership article explores the mechanistic, translational, and strategic dimensions of c-Myc inhibition in cancer research, with a focus on the small-molecule inhibitor 10074-G5. Drawing on recent discoveries in the c-Myc/TERT/NFκB axis and microRNA-mediated oncogenesis, it provides actionable guidance for researchers seeking robust, reproducible modulation of c-Myc-driven pathways. Building on APExBIO’s validated protocols and real-world assay scenarios, the article bridges molecular mechanism and functional cancer model design, highlighting both the competitive landscape and the unique value proposition of 10074-G5.

• 6-Thioguanine Inhibits EV71 Replication via BIRC3-Autophagy

  2026-05-24

  This study demonstrates that 6-thioguanine effectively inhibits enterovirus 71 (EV71) replication in vitro by suppressing BIRC3-mediated autophagy, a novel antiviral mechanism. The findings provide a mechanistic basis for further exploration of 6-thioguanine as a candidate therapy for EV71-associated diseases and highlight the importance of targeting autophagy pathways in antiviral research.

• ERK Inhibition Mitigates Mitochondrial Fragmentation in CIRI

  2026-05-23

  Yuan et al. demonstrate that ERK inhibition protects SH-SY5Y cells from oxygen-glucose deprivation/reoxygenation injury by downregulating autophagy through modulation of Drp1/Mfn2-dependent mitochondrial dynamics. Their findings clarify a pathological signaling axis in cerebral ischemia-reperfusion injury and suggest refined strategies for neuroprotection.

• Excessive Calpain Disrupts BDNF/TrkB and Impairs Offspring C

  2026-05-22

  Zhang et al. (2025) provide mechanistic evidence that excessive calpain activation following maternal non-obstetric surgery impairs offspring cognition by downregulating BDNF/TrkB signaling and altering hippocampal structure. Postnatal pharmacological calpain inhibition with MDL 28170 partially rescues neuronal and behavioral deficits, highlighting a potential intervention point for neurodevelopmental protection.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-05-22

  Schwartz's dissertation introduces a rigorous framework for differentiating drug-induced growth inhibition from cell death in in vitro cancer models. By dissecting the interplay between proliferative arrest and cytotoxicity, the study enables more precise interpretation of anti-cancer agent efficacy, informing both experimental design and translational relevance.

• ARCA EGFP mRNA (5-moUTP): Optimized Polyadenylated mRNA for

  2026-05-21

  ARCA EGFP mRNA (5-moUTP) sets a new standard for reliable, fluorescence-based transfection control in mammalian cells, thanks to its advanced ARCA capping, 5-methoxyuridine modification, and optimized poly(A) tail. This polyadenylated mRNA delivers superior expression, stability, and minimized innate immune response, streamlining experimental workflows and troubleshooting.

• SIRT4-Mediated Glutamine Metabolism: Mitigating Liver Fibros

  2026-05-21

  The referenced study uncovers how modulating SIRT4 and glutamine metabolism in hepatic stellate cells (HSCs) can alleviate liver fibrosis by restraining cell activation and proliferation. These insights reveal new targets for intervention and support the importance of mitochondrial metabolic regulation in fibrotic disease.

• URB597 (KDS-4103): Decoding FAAH Inhibition in Translational

  2026-05-20

  Explore how URB597, a potent FAAH inhibitor, enables advanced translational research in endocannabinoid signaling and pain models. This in-depth analysis offers novel perspectives on experimental design and interpretation, filling knowledge gaps left by prior protocols.

• Translating Metabolic Pathway Modulation: Strategic Advances

  2026-05-20

  This thought-leadership article explores how mechanistic insights into metabolic regulation, exemplified by propranolol's impact on burn-induced hypermetabolism, inform strategic approaches for translational researchers. We examine the DiscoveryProbe™ Metabolism-related Compound Library as a next-generation platform for interrogating metabolic pathways, comparing its capabilities to emerging standards, and offering actionable guidance for high-impact metabolism research.

• Aconitase Activity Colorimetric Assay Kit: Precision in TCA

  2026-05-19

  The Aconitase Activity Colorimetric Assay Kit empowers researchers to quantify iron-sulfur protein aconitase activity with unmatched sensitivity and speed, enabling robust assessment of metabolic reprogramming and oxidative damage. This article delivers actionable protocol strategies, troubleshooting insights, and translational workflow enhancements, bridging recent immunometabolic findings to practical bench applications.

• Nanocrystal Thermogel Enhances CDK4/6 Inhibitor Delivery in

  2026-05-19

  This study introduces a nanocrystal-integrated, thermoresponsive in situ gel platform to deliver the CDK4/6 inhibitor palbociclib directly into breast tumors. The innovation addresses solubility challenges, enables sustained drug release, and significantly boosts local anticancer efficacy while reducing systemic toxicity.

493 records 10/33 page Previous Next First page 上5页 678910 下5页 Last page